Cronos is a global cannabinoid company that develops, produces, and distributes cannabis products and cannabinoid-based consumer goods across adult-use and medical markets. The company operates a diverse brand portfolio and generates revenue through sales to provincial cannabis control authorities and private retailers in Canada, distribution of medical cannabis through third-party partners globally, and the development of intellectual property in product formulation and processing technology. Cronos competes on product quality, production efficiency, innovation, and brand recognition, supported by substantial capitalization and production facilities spanning North America and international jurisdictions including Israel, Germany, and the United Kingdom.